FULC Fulcrum Therapeutics Inc
P/E
--
Forward P/E
--
Price/Sales
2.657
Beta
2.627
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Fulcrum Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 18, 2026
Analysts expect Fulcrum Therapeutics to report zero revenue and a consensus net loss of $0.10 per share, with the current stock price of $3.77 trading well...
Fulcrum Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 11, 2026
Fulcrum Therapeutics is projected to post a Q3 2026 loss of $0.10 per share on revenue of $0.83 million, with the stock currently trading at $2.15 against a...
Fulcrum Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Fulcrum Therapeutics is expected to report zero revenue and a consensus loss of $0.10 per share for Q3 2026, with the stock currently trading at $3.71 versus...